Axel Ullrich
PhD
Director Emeritus
👥Biography 个人简介
Dr. Axel Ullrich is a pioneering molecular oncologist who cloned and characterized EGFR, HER2, and the insulin receptor, discoveries that transformed cancer targeted therapy. His demonstration that HER2 amplification drives cancer provided the conceptual basis for trastuzumab development. He was also a key early scientist in the Bcr-Abl kinase drug discovery pathway. His contributions to RTK-targeted drug design have shaped the modern era of precision oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Axel Ullrich 的研究动态
Follow Axel Ullrich's research updates
留下邮箱，当我们发布与 Axel Ullrich（Max Planck Institute of Biochemistry）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment